Lipid levels and their genetic regulation in patients with familial hypercholesterolemia and familial defective apolipoprotein B-100: The MEDPED Slovakia Project

Atherosclerosis Supplements

Volumn 4, Issue 3, 2003, Pages 3-5

  Vohnout, Branislav ^a,j   Rašlová, Katarína ^a   Gašparovič, Juraj ^a   Franeková, Jana ^b   Fábryová, Lubomíra ^c   Belošovičová, Martina ^d   Kováč, Gustáv ^e   Šebová, Claudia ^e   Rajecová, Eva ^f   Stavný, Jozef ^g   Babjak, Miron ^h   Donati, Maria B ⁱ   Iacoviello, Licia ^j  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b OKB NsP ilina   (Slovakia)

^c Spol S RO   (Slovakia)

^d FNsP Bratislava   (Slovakia)

^e FRO FNsP Bratislava pracovisko Ru inov   (Slovakia)

^f UTaRCH Bratislava   (Slovakia)

^g OKB NsP Poprad   (Slovakia)

^h OKB NsP Humenne   (Slovakia)

ⁱ CATHOLIC UNIVERSITY   (Italy)

^j Angela Valenti Lab Thromb P   (Italy)

more..

Author keywords

Apo E; Familial defective Apo B 100; Familial hypercholesterolemia; Polymorphism

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 10744233946     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(03)00023-0     Document Type: Article

References (8)

1. WHO Familial Hypercholesterolemia. Human Genetics Program. Division of Noncommunicable Diseases. Geneva, WHO/HGN/FH/CONC/98.7. p. 1-45.
2. Hansen P.S., Defesche J.C., Kastelein J.J.P.et al. Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries. Arterioscler. Thromb. Vasc. Biol. 17:1997;741-747.
3. Miserez A.R., Keller W. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 15:1995;1719-1729.
4. Hill J.S., Hayden M.R., Frohlich J., Pritchard P.H. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous Familial Hypercholesterolemia. Arterioscler. Thromb. 11:1991;290-297.
5. Williams R.R., Hunt S.C., Schumacher C.et al. Diagnosing heterozygous Familial Hypercholesterolemia using new practical criteria validated by molecular genetics. Am. J. Cardiol. 72:1993;171-176.
6. Schuster H., Rauh G., Muller S.et al. Polymerase chain reaction protocol for rapid diagnosis of familial defective apolipoprotein B-100. Anal. Biochem. 204:1992;22-25.
7. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:1990;545-548.
8. Raslova K., Smolkova B., Vohnout B.et al. Risk factors for atherosclerosis in survivors of myocardial infarction and their spouses: comparison to controls without personal and family history of atherosclerosis. Metabolism. 50:2001;24-29.